• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Women’s Sexual Health: Wisp Expands At-Home Diagnostics

by Jasmine Pennic 06/27/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Wisp, a women’s telehealth provider in the U.S., serving over 1.5 million patients nationwide, is significantly expanding its diagnostics vertical with the launch of new, affordable at-home testing kits. 

– The expansion offers 360-degree sexual and reproductive health care directly to patients’ homes, cutting wait times, removing stigma, and empowering individuals to take control of their health.

Growing Suite of At-Home Testing Solutions

Building on its initial diagnostic launch in May, Wisp is now offering an even broader range of at-home testing options. These new kits cater to some of the most common sexual and reproductive health concerns:

  • Bacterial Vaginosis (BV) and Yeast Infections: Priced at $159, this swab test kit provides convenient and discreet testing for two prevalent vaginal health issues.
  • Herpes Simplex Virus (HSV-1 & HSV-2): For $169, individuals can now access an at-home swab test for both types of the herpes virus.
  • Human Papillomavirus (HPV): A critical screening tool, the HPV swab test kit is available for $105, offering fast and convenient screening from home.

These new additions complement Wisp’s existing diagnostic offerings, which include comprehensive panels for common STIs, such as:

  • Common STI Panel: Testing for Chlamydia, Gonorrhea, and Trichomoniasis.
  • 3-Site Panel: For Chlamydia and Gonorrhea testing across multiple anatomical sites.
  • Mycoplasma Genitalium (M-Gen) Panel: A dedicated test for Mycoplasma Genitalium.

Why At-Home Testing Matters: Accessibility, Affordability, and Empowerment

Wisp’s expansion into these new diagnostic areas underscores its commitment to making comprehensive sexual health care more accessible than ever. The at-home testing model addresses several critical barriers patients often face when seeking care:

  • Unmatched Affordability: Wisp proudly offers the lowest price point in the market for all its test kits, making essential diagnostics financially attainable for more individuals. (Note: While the provided data states this, it’s worth noting some other services might have different pricing models or insurance acceptance.)
  • Integrated Care with Free Consultations: Every test kit purchased includes a free virtual consultation with a licensed medical provider. This crucial step ensures that patients receive appropriate follow-up care and, if necessary, prescriptions directly to their local pharmacy or via discreet home delivery.
  • Removing Stigma and Maximizing Convenience: The discreet nature of at-home testing eliminates the need for potentially uncomfortable in-person clinic visits. This model empowers patients to take proactive steps for their health from the privacy and comfort of their own homes, significantly reducing wait times and increasing overall convenience.
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

The AI Paradox in Healthcare: Notable CEO Shares Why Moving Too Slowly is a Greater Risk

Most-Read

Patient Square Capital Acquires Premier in $2.6B Deal

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

CVS Health Subsidiary Omnicare Files for Bankruptcy to Tackle Financial Challenges

CVS Health Subsidiary Omnicare Files for Bankruptcy to Tackle Financial Challenges

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Corti Joins Coalition for Health AI to Advance Responsible and Safe AI in Healthcare

Joint Commission and CHAI Release First-Ever Guidance for Responsible AI in Healthcare

71% of Hospitals Now Use Predictive AI, But a Digital Divide Remains

71% of Hospitals Now Use Predictive AI, But a Digital Divide Remains

PHTI Report: Virtual OUD Solutions are Effective, But Don't Substantially Reduce Costs

PHTI Report: Virtual OUD Solutions are Effective, But Don’t Substantially Reduce Costs

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |